SHELTON, US - ACCESSWIRE - June 30, 2020 - NanoViricides, Inc. (NYSE American: NNVC) (the "Company") a leader in the development of highly effective antiviral therapies based on a novel nanomedicines ...
The maker of a drug shown to shorten recovery time for severely ill COVID-19 patients says it will charge $2,340 for a typical treatment course for people covered by government health programs in the ...
TAIPEI (Taiwan News) — A team of scientists at Taiwan's Chang Gung University (CGU) has found a monoclonal antibody (mAb) that can inhibit the Wuhan coronavirus (COVID-19) by over 90 percent...
TAIPEI (Taiwan News) — Taiwan's Ministry of Science and Technology (MOST) on Thursday (May 14) announced that academic institutions in Taiwan and Australia will be teaming up to research the...
News that an experimental drug seems to be the first effective treatment for the new coronavirus has unleashed a flurry of interest from doctors and patients — and questions about how soon it might be...
More than half of a group of severely ill coronavirus patients improved after receiving an experimental antiviral drug, although there’s no way to know the odds of that happening without the drug beca...
___
Stocks have first back-to-back gains since sell-off began
NEW YORK (AP) — Stocks scored their first back-to-back gains since a brutal sell-off began five weeks ...
WASHINGTON (AP) — Facing public criticism, the maker of a promising coronavirus drug said Wednesday it will waive a special regulatory designation that could have allowed it to block competition and b...
___
Dow has best day since 1933 as Congress nears deal on aid
NEW YORK (AP) — The Dow Jones Industrial Average surged to its best day since 1933 as Congress and the...
WASHINGTON (AP) — The pharmaceutical giant that makes a promising coronavirus drug has registered it as a rare disease treatment with U.S. regulators, a status that can potentially be worth millions i...
NEW YORK (AP) — Stocks that moved heavily or traded substantially on Monday:
Gilead Sciences Inc., down 65 cents to $72.61.
The biotechnology company suspended emer...
NEW YORK (AP) — President Donald Trump called NBC News correspondent Peter Alexander a “terrible reporter” during Friday's White House news briefing for asking what he would say to Americans who are s...
TAIPEI (Taiwan News) — Taiwan has started clinical trials for the use of the antiviral drug remdesivir to treat Wuhan coronavirus (COVID-19), the Central Epidemic Command Center (CECC) announced...
TAIPEI (Taiwan News) — The inventor of a cocktail therapy for AIDS, Dr. David Ho contends that 98 percent of the patients infected with the novel coronavirus (COVID-19) will recover — beli...
TAIPEI (Taiwan News) — Taiwan has been given the green light to join with the U.S. in starting clinical trials for the use of the antiviral drug remdesivir to treat the Wuhan coronavirus, announ...
